The global research antibodies market was valued at USD 1.72 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% through 2034. This robust expansion is underpinned by escalating global investment in basic and translational life sciences research, yet regional trajectories diverge significantly due to disparities in funding ecosystems, regulatory stringency,...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek